Kaneko Mai, Fukasawa Hirotaka, Ishibuchi Kento, Niwa Hiroki, Yasuda Hideo, Furuya Ryuichi
Renal Division, Department of Internal Medicine, Iwata City Hospital, Japan.
First Department of Medicine, Hamamatsu University School of Medicine, Japan.
Intern Med. 2018 Dec 15;57(24):3593-3596. doi: 10.2169/internalmedicine.1055-18. Epub 2018 Aug 24.
Patients on hemodialysis often have carnitine deficiency. We herein report a woman who experienced the dramatic improvement of cardiac dysfunction after intravenous L-carnitine administration. We also investigated the myocardial fatty acid metabolism using I-labeled β-methyl-p-iodophenyl-pentadecanoic acid (BMIPP) single-photon emission computed tomography (SPECT) before and after L-carnitine therapy, and the impaired metabolism was ameliorated. Taken together, these findings indicate that L-carnitine therapy improved cardiac dysfunction via the amelioration of the abnormal myocardial fatty acid metabolism, at least in part.
接受血液透析的患者常存在肉碱缺乏。我们在此报告一名女性,其在静脉注射L-肉碱后心脏功能障碍得到显著改善。我们还在L-肉碱治疗前后,使用I标记的β-甲基-对碘苯基十五烷酸(BMIPP)单光子发射计算机断层扫描(SPECT)研究了心肌脂肪酸代谢,发现受损的代谢得到了改善。综上所述,这些发现表明,L-肉碱治疗至少部分通过改善异常的心肌脂肪酸代谢改善了心脏功能障碍。